Publications by Dag Sigurd Fosmark
8 publications found
Original articles
A Pilot Study of Implementing Diabetic Retinopathy Screening in the Oslo Region, Norway: Baseline Results
Biomedicines, 11 (4)
DOI 10.3390/biomedicines11041222, PubMed 37189840
Hand, shoulder and back stiffness in long-term type 1 diabetes; cross-sectional association with skin collagen advanced glycation end-products. The Dialong study
J Diabetes Complications, 31 (9), 1408-1414
DOI 10.1016/j.jdiacomp.2017.06.007, PubMed 28705609
Increased retinopathy occurrence in type 1 diabetes patients with increased serum levels of the advanced glycation endproduct hydroimidazolone
Acta Ophthalmol, 87 (5), 498-500
DOI 10.1111/j.1755-3768.2008.01300.x, PubMed 18631328
Increased vitreous levels of hydroimidazolone in type 2 diabetes patients are associated with retinopathy: a case-control study
Acta Ophthalmol Scand, 85 (6), 618-22
DOI 10.1111/j.1600-0420.2007.00913.x, PubMed 17488318
Low cumulative incidence of proliferative retinopathy in childhood-onset type 1 diabetes: a 24-year follow-up study
Diabetologia, 49 (10), 2281-90
DOI 10.1007/s00125-006-0364-7, PubMed 16955208
Increased serum levels of the specific advanced glycation end product methylglyoxal-derived hydroimidazolone are associated with retinopathy in patients with type 2 diabetes mellitus
Metabolism, 55 (2), 232-6
DOI 10.1016/j.metabol.2005.08.017, PubMed 16423631
Other articles
What effect does patient access to medical records have on their content?
Tidsskr Nor Laegeforen, 136 (19), 1614
DOI 10.4045/tidsskr.16.0800, PubMed 27790885
Theses
Diabetic retinopathy: from glycation to clinical aspects
In Series of dissertations submitted to the Faculty of Medicine, University of Oslo, Unipub, Oslo, no. 671, 1 b. (flere pag.)
BIBSYS 082430713, ISBN 978-82-8072-897-5